 Bristol-Myers Squibb Co NYSE: BMY is planning to tender its shares in Acceleron Pharma Inc NASDAQ: XLRN after Merck Co Inc NYSE: MRK agreed to buy the biotechnology company for 11.5 billion, Bloomberg reported citing people with knowledge of the matter. Bristol-Myers holds an 11.5 stake in Acceleron. 